Some days the tape hands you a puzzle — a chip giant gets punished, a connector company gets crowned, and a plane lessor prints fifty-cent margins like it is nothing.

Some days the tape hands you a puzzle — a chip giant gets punished, a connector company gets crowned, and a plane lessor prints fifty-cent margins like it is nothing. Let us figure out what is actually happening.

Start with Arm Holdings, because a gap down of eight point one percent on twenty-two point eight percent revenue growth is the most interesting contradiction on the slate today. The number that matters is the P/E of three hundred thirteen point five — and when you are priced for perfection at that multiple, guidance whispers are thunder. EPS growth came in at thirteen point six percent against revenue growth of twenty-two point eight, which tells you margins compressed somewhere between the top line and the bottom, and at that valuation the Street does not forgive compression, it evacuates. This one gets the full teardown — because the gap tells you the market saw something in the forward numbers that the headline beat obscured, and I want to find it.

Amphenol is the cleanest print on the board today. Revenue up fifty-four point four percent, EPS up sixty-eight point six percent, and the stock gaps up four and a half percent — that is a company where operating leverage is working exactly as it should. At a P/E of forty-two point six that growth rate still looks like it has room; the question for the teardown will be how much of that revenue growth is organic versus acquired.

Automatic Data Processing gaps up three and a half percent on six point nine percent revenue growth, which sounds modest until you clock the net margin and remember this is a float-income business — when rates stay elevated, their client funds balances print money before they process a single payroll. Steady, and the Street finally noticed.

AerCap is the knife-twist of the day. A fifty point seven percent net margin and EPS more than doubling — one hundred two point five percent growth year over year — and the stock gaps down three and a half percent anyway. Here is why: that EPS number is almost certainly driven by aircraft sale gains and lease incentive timing, not recurring cash yield, and when a lessor at a P/E of six still gets sold on a blowout print, the market is telling you it does not trust the quality of those earnings — and with aircraft delivery backlogs stretching to the end of the decade, that distrust has a long runway.

Biogen gaps up one point eight percent on revenue growth of one point two percent and EPS down eight percent year over year. The market is not buying the fundamentals — it is buying optionality on the pipeline, and that is a different bet entirely.

Air Products and Chemicals barely moves — up half a point — despite EPS growing thirty-seven point four percent. Net margin is fine, but with revenue only up three point seven percent, that EPS growth smells like buybacks and restructuring, not business acceleration. Worth checking the share count.

American Water Works prints eight point one percent revenue growth with EPS growth of only two point nine percent — regulated utility math, where capital recovery lags investment. No drama, no gap noted. Exactly what the model says it should be.

Boston Scientific reported today. Limited data available — I will not dress that up. When the filing is in hand, we will work it properly.

Coming days, I am going deep on two: Arm Holdings, because I want to know exactly where the margin went and what the guidance corridor actually implies at that multiple — and Amphenol, because fifty-four percent revenue growth deserves a forensic look at what is organic and what is paper.

That is the menu. The numbers were always there — most people just do not look. See you at the next filing.